Literature DB >> 16876018

Landau-Kleffner syndrome with mitochondrial respiratory chain-complex I deficiency.

Hoon-Chul Kang1, Heung Dong Kim, Young Mok Lee, Si Hoon Han.   

Abstract

Landau-Kleffner syndrome is characterized by epileptic aphasia associated with electrical status epilepticus of slow wave sleep. A 5-year-old female, who had manifested normal developmental progress, was referred with principal complaints of fluctuating sensory aphasia and bizarre behavior during the preceding 4 months. Landau-Kleffner syndrome was confirmed by clinical and electroencephalographic features; in addition, the patient's mitochondrial respiratory chain-complex I deficiency was confirmed by fibroblast culture with the evidence of energy metabolism disorder. This patient's seizures were intractable to many antiepileptic drugs, adrenocorticotrophic hormone, and intravenous immunoglobulin, with catastrophic cognitive and behavioral decline, but the seizures were successfully controlled by ketogenic diet with supplementary mitochondrial cocktail including coenzyme Q10, riboflavin, L-carnitine, and high-dose multivitamins. The patient finally regained fully normal cognitive functioning. Landau-Kleffner syndrome with mitochondrial respiratory chain-complex I deficiency was controlled in this case by ketogenic diet and supplementary mitochondrial cocktail therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876018     DOI: 10.1016/j.pediatrneurol.2006.01.012

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  7 in total

Review 1.  Ketogenic diets in patients with inherited metabolic disorders.

Authors:  S Scholl-Bürgi; A Höller; K Pichler; M Michel; E Haberlandt; D Karall
Journal:  J Inherit Metab Dis       Date:  2015-06-25       Impact factor: 4.982

2.  A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease.

Authors:  David N Ruskin; Jessica L Ross; Masahito Kawamura; Tiffany L Ruiz; Jonathan D Geiger; Susan A Masino
Journal:  Physiol Behav       Date:  2011-04-09

3.  Initial experiences with proton MR spectroscopy in treatment monitoring of mitochondrial encephalopathy.

Authors:  Seung-Koo Lee; Jinna Kim; Heung Dong Kim; Joon Soo Lee; Young Mock Lee
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

4.  Nonspecific mitochondrial disease with epilepsy in children: diagnostic approaches and epileptic phenotypes.

Authors:  Hoon-Chul Kang; Ji Won Kwon; Young Mock Lee; Heung Dong Kim; Hong Jin Lee; Si Houn Hahn
Journal:  Childs Nerv Syst       Date:  2007-06-19       Impact factor: 1.475

Review 5.  Nutritional interventions in primary mitochondrial disorders: Developing an evidence base.

Authors:  Kathryn M Camp; Danuta Krotoski; Melissa A Parisi; Katrina A Gwinn; Bruce H Cohen; Christine S Cox; Gregory M Enns; Marni J Falk; Amy C Goldstein; Rashmi Gopal-Srivastava; Gráinne S Gorman; Stephen P Hersh; Michio Hirano; Freddie Ann Hoffman; Amel Karaa; Erin L MacLeod; Robert McFarland; Charles Mohan; Andrew E Mulberg; Joanne C Odenkirchen; Sumit Parikh; Patricia J Rutherford; Shawne K Suggs-Anderson; W H Wilson Tang; Jerry Vockley; Lynne A Wolfe; Steven Yannicelli; Philip E Yeske; Paul M Coates
Journal:  Mol Genet Metab       Date:  2016-09-20       Impact factor: 4.797

6.  The pleiotropic effects of decanoic acid treatment on mitochondrial function in fibroblasts from patients with complex I deficient Leigh syndrome.

Authors:  Marta Kanabus; Elisa Fassone; Sean David Hughes; Sara Farahi Bilooei; Tricia Rutherford; Maura O' Donnell; Simon J R Heales; Shamima Rahman
Journal:  J Inherit Metab Dis       Date:  2016-04-14       Impact factor: 4.982

Review 7.  Use of the Ketogenic Diet to Treat Intractable Epilepsy in Mitochondrial Disorders.

Authors:  Eleni Paleologou; Naila Ismayilova; Maria Kinali
Journal:  J Clin Med       Date:  2017-05-26       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.